Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$214,138,842
+$12,496,037 QoQ
Shares Held
850,973
-8.2% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#153
of 4,167 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 68%
None 32%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $2,503,359,774 across 18 Drug Manufacturers - General names. ABBV ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
692,569 | $830,688,102 | |
| 2 | JNJ |
Johnson & Johnson
|
1,312,753 | $333,399,877 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,433,801 | $312,743,428 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,946,858 | $245,966,038 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
850,973 | $214,138,842 | |
| 6 | AMGN |
Amgen Inc
|
430,230 | $155,794,886 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,580,079 | $148,664,149 | |
| 8 | AZN |
Astrazeneca PLC
|
447,620 | $84,877,702 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,138,842 | 850,973 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $201,642,805 | 927,136 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $420,665,853 | 1,841,069 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $442,479,652 | 1,911,029 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $295,330,326 | 1,591,048 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $263,650,117 | 1,258,353 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $254,433,879 | 1,431,817 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $245,772,942 | 1,244,546 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $200,877,875 | 1,171,163 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $153,635,036 | 843,685 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $269,682,357 | 1,740,223 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $264,595,063 | 1,775,091 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $194,748,980 | 1,445,476 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $122,025,145 | 765,672 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $86,893,169 | 537,672 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $54,268,885 | 404,358 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $54,629,873 | 356,685 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $58,984,533 | 363,855 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $47,012,098 | 347,209 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||